• Bath & Body Works has already launched a limited-edition Star Wars: The Mandalorian and Grogu collection, featuring three new franchise-inspired fragrances across body care, home fragrance, candles and accessories in the US and Canada, with international markets to follow by the end of 2026.
• The collaboration with Disney extends Bath & Body Works’ broader brand partnership strategy, using cinematic storytelling and loyalty-member exclusives to keep customers emotionally connected to its products beyond a single theater visit.
• We’ll now examine how this Disney collaboration and its three original Star Wars-inspired scents may influence Bath & Body Works’ investment narrative.

Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

Bath & Body Works Investment Narrative Recap

To own Bath & Body Works, you need to believe it can reinvigorate growth by deepening emotional connections with customers, expanding internationally and improving digital execution, despite recent earnings pressure and high debt. The Mandalorian and Grogu collaboration reinforces its storytelling and loyalty strengths, but on its own is unlikely to materially change the key near term catalyst, which remains proof that brand and product refreshes can reaccelerate revenue, or the biggest risk, that younger customer growth stays stubbornly weak.

The appointment of Veronique Gabai-Pinsky as the first chief brand and product officer looks particularly relevant here, given her fragrance and luxury background and the company’s growing slate of collaborations with partners like Disney and Vera Bradley. Her role sits at the center of the main catalyst investors are watching: whether Bath & Body Works can turn product innovation and more disciplined assortments into more consistent sales and healthier margins without leaning too hard on promotions.

Yet behind the buzz of Star Wars themed candles and collectibles, investors should also be aware of the risk that heavy reliance on limited collections and promotions could...

Bath & Body Works' narrative projects $7.5 billion revenue and $668.7 million earnings by 2029. This requires 1.0% yearly revenue growth and about a $19.7 million earnings increase from $649.0 million today.

Uncover how Bath & Body Works' forecasts yield a $27.62 fair value, a 43% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already saw Disney style collaborations as part of a bigger product and channel refresh, with forecasts for revenue of about US$8.3 billion and earnings near US$862 million by 2028, while others worry that weak digital performance and mall dependence could cap the benefit. As you weigh this new Mandalorian launch, it is worth remembering that reasonable people can look at the same brand and reach very different conclusions about its potential.

Explore 8 other fair value estimates on Bath & Body Works - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Bath & Body Works research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Bath & Body Works research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bath & Body Works' overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 40 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.